SCHEMBL14456964

SCHEMBL14456964

Nc1cc(CN2CCC(C(=O)N3CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)CC2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.57
▸ POLB P06746 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ GAA P10253 1/20 0.53
▸ KMT2A Q03164 1/20 0.52
▸ F10 P00742 1/20 0.52
▸ CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14456975 0.93 CNR1 (0.60) CNR1POLBALDH1A1LMNATSHR
SCHEMBL14456976 0.92 POLB (0.52) CNR1POLBALDH1A1LMNATSHR
SCHEMBL14457004 0.91 ALDH1A1 (0.54) POLBALDH1A1LMNATSHRKMT2A
SCHEMBL14456977 0.90 POLB (0.56) CNR1POLBALDH1A1LMNATSHR
SCHEMBL14456982 0.88 CYP3A4 (0.56) POLBALDH1A1LMNATSHRCYP3A4
SCHEMBL14456983 0.88 CYP3A4 (0.49) NPSR1ALDH1A1CYP3A4
SCHEMBL14456956 0.87 CNR1 (0.69) CNR1NPSR1POLBALDH1A1LMNA
SCHEMBL14456974 0.87 CYP3A4 (0.53) POLBALDH1A1LMNATSHRCYP3A4
SCHEMBL8418285 0.87 CYP3A4 (0.52) CYP3A4
SCHEMBL14456989 0.87 POLB (0.49) POLBALDH1A1LMNATSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
US-7238688-B2 Piperidine compounds SCHERING CORPORATION (US) 2007-07-03 — — US disclosed
US-7238688-B2 Piperidine compounds SCHERING CORPORATION (US) 2007-07-03 — — US disclosed
Send feedback